这也意味着，这起自2022年就爆发的逾期事件，历时近三年终于有了阶段性进展。 【导读】中信证券被判赔偿富安娜本金损失近2930万元 中国基金报记者 孙越 家纺龙头富安娜与"券业一哥"中信证券的理财纠纷，迎来一审判决！ 12月25日，富安娜发布公告称，其起诉中信证券、招商银行广州分行的金融委托理财合同纠纷案，获法 院一审判决：中信证券需赔偿其本金损失近2930万元，涉案资管计划后续清算回款由原告和中信证券各 分50%。 1.2亿元买理财仅收回一成本金 另外，法院还明确，富安娜之前已从资产专用账户提取559.02万元，且资产专用账户还收到西部信托的 投资回款3583.71万元，回款目前尚未提取，中信证券和招商银行广州分行要配合富安娜足额提取。 上市公司理财偏好趋稳 风险意识显著提升 近年来，因资管产品嵌套、通道业务造成的上市公司理财纠纷时有出现。 法院一审判了 先回溯下这起纠纷的来龙去脉。 2021年，富安娜斥资1.2亿元购买了中信证券的一款定制资管计划——中信证券富安FOF定制1号单一资 产管理计划（以下简称富安1号）。原本是奔着稳健收益去的，没想到在2022年3月19日，这款产品突然 出现逾期兑付。截至202 ...

家纺龙头富安娜（002327）与"券业一哥"中信证券（600030）的理财纠纷，迎来一审判决！ 12月25日，富安娜发布公告称，其起诉中信证券、招商银行广州分行的金融委托理财合同纠纷案，获法院一审判决：中信证券需赔偿其本金损失近2930万 元，涉案资管计划后续清算回款由原告和中信证券各分50%。 这也意味着，这起自2022年就爆发的逾期事件，历时近三年终于有了阶段性进展。 1.2亿元买理财仅收回一成本金 法院一审判了 先回溯下这起纠纷的来龙去脉。 2021年，富安娜斥资1.2亿元购买了中信证券的一款定制资管计划——中信证券富安FOF定制1号单一资产管理计划（以下简称富安1号）。原本是奔着稳 健收益去的，没想到在2022年3月19日，这款产品突然出现逾期兑付。截至2024年末，富安娜仅从中信1号产品托管账户上提取1430.23万元，剩余产品本 金1.06亿元及相关预期固定收益到期未能收回。 富安1号的主要持仓产品为东方红货币B及北大资源杭州海港城，其中，北大资源杭州海港城是杭州当地有名的"烂尾楼"，项目债务人浙江蓝德置业发展 有限公司早已实质违约，主要连带责任保证担保方北大方正集团重整计划又不及预期，导致富安1 ...

本文由 AI 算法生成，仅作参考，不涉投资建议，使用风险自担 【12月17日数据：今年A股公司买理财金额同比降18.76%】今年以来，截至12月16日，1147家A股上市 公司购买1.5万个理财产品，认购金额合计9440.99亿元，同比下降18.76%。 各类理财产品中，结构性存 款最受青睐，认购金额5638.34亿元，占比59.72%。 其次是银行理财产品，认购金额1081.24亿元。存款 产品、券商理财产品认购金额分别为769.69亿元、658.07亿元。 ...

近期，上市公司利用闲置资金购买理财产品的现象引发市场热议。将闲置资金用于购买理财产品一直是 上市公司提升资金使用效率的重要方式，受访专家表示，上市公司购买理财时，需要结合自身发展阶 段、实际资金需求等，审慎制定资金使用计划。 上市公司购买的理财产品通常包括存款、银行理财产品、券商理财产品等。例如，摩尔线程在公告中表 示，拟使用部分闲置募集资金购买包括但不限于协定存款、通知存款、定期存款、结构性存款、大额存 单、收益凭证等安全性高、流动性好的保本型产品。 "相较于存款等其他类型的理财产品，券商理财产品在收益率方面具备一定优势。"盘古智库（北京）信 息咨询有限公司高级研究员余丰慧在接受《证券日报》记者采访时表示，作为具备投研优势的专业机 构，券商在底层资产配置、风险控制方面的能力较受认可，产品设计也较为灵活，能够适配上市公司多 元化的理财需求，且券商理财产品尤其是固收类产品具备较强的安全性和流动性，风险较低。整体来 看，券商理财产品能够兼顾稳健与收益，因此具备较强的市场竞争力。 从单家上市公司认购理财产品的金额来看，有7家上市公司年内认购理财产品金额在100亿元以上。具体 来看，截至12月16日，年内认购理财产品 ...

Core Viewpoint - The company, TBEA Co., Ltd. (特变电工), announced plans to utilize its phased idle funds for entrusted wealth management, indicating a strategic move to optimize its financial resources [1] Group 1: Financial Management Strategy - The company plans to invest in bank wealth management products and securities firm wealth management products (such as income certificates), with a daily balance not exceeding 2 billion yuan [1] - Additionally, the company will invest in other types of wealth management products (such as treasury reverse repurchase agreements), with a daily balance not exceeding 1 billion yuan [1]

Group 1 - The company plans to use idle raised funds for cash management, ensuring it does not affect the normal implementation of fundraising projects and guarantees the safety of the raised funds [3][11][19] - The investment types include structured deposits, large certificates of deposit, reverse repos, broker income certificates, and broker wealth management products, all of which are high-security and liquid principal-protected products [2][7][8] - The total investment amount will not exceed 1.4 billion yuan from publicly issued convertible bonds and 15.4 billion yuan from non-publicly issued stock [2][4][7] Group 2 - The cash management is aimed at enhancing the value of idle funds and increasing company revenue while protecting the interests of all shareholders [3][19] - The board of directors approved the cash management proposal on December 9, 2025, during the ninth meeting of the fifth board [13][30] - The cash management products will be managed by reputable financial institutions that provide principal protection, and the investment period will not exceed 12 months [8][9][30] Group 3 - The company will ensure that the cash management does not affect the normal operations and funding needs of the company [19][33] - The financial products will be recorded as trading financial assets or other current assets in the balance sheet, with interest income recorded in the profit statement [19][33] - The company will disclose cash management details in accordance with relevant regulations and guidelines [12][32]

Core Viewpoint - Antu Biology announced the approval of a proposal to utilize idle raised funds for cash management to enhance fund efficiency [1] Group 1: Fund Management - The company plans to use up to 140 million yuan of idle funds from convertible bonds and up to 1.54 billion yuan from non-publicly issued stock for investments in safe and liquid principal-protected products [1] - The investment options include structured deposits, large certificates of deposit, reverse repos of government bonds, broker income certificates, and broker wealth management products [1] - The approved cash management plan is valid for 12 months from the date of the board's approval, allowing for rolling use of funds within the specified limits [1] Group 2: Impact on Operations - The company clarified that this cash management initiative will not affect the progress of investment projects funded by the raised capital or the normal production and operation of the company [1]

Group 1 - The company held its first extraordinary general meeting of shareholders on December 2, 2025, in Shaoxing, Zhejiang Province [2][3] - All resolutions presented at the meeting were approved, including the cancellation of the supervisory board and adjustments to the number of directors [4][5] - The meeting was conducted in compliance with relevant laws and regulations, with legal counsel present to witness the proceedings [7] Group 2 - The company announced the use of idle self-owned funds for entrusted wealth management, with a maximum amount not exceeding RMB 300 million [10] - As of the announcement date, the company had utilized RMB 260 million to purchase wealth management products from CITIC Securities [11] - The company emphasized that the wealth management activities would not affect its normal business operations and would enhance fund utilization efficiency [12]

Core Viewpoint - The company has successfully redeemed a total of 247.12 million yuan in financial products, recovering both the principal and earning a return of 2.50 million yuan during the specified period [1] Group 1: Financial Performance - From September 19, 2025, to November 28, 2025, the company redeemed financial products amounting to 247.12 million yuan, which includes the recovery of the principal [1] - The total earnings from these financial products during the redemption period amounted to 2.50 million yuan [1] Group 2: Financial Product Details - As of November 28, 2025, the company's remaining entrusted financial products balance is 1,059.77 million yuan [1] - The breakdown of the remaining financial products includes: - Bank financial products: 249.54 million yuan - Securities firm financial products: 140 million yuan - Trust products: 670.24 million yuan [1]

Core Viewpoint - The company plans to invest up to 500 million yuan in various financial products using its idle funds, which has been approved by the board of directors and is valid for 12 months [2] Group 1 - The company intends to use its own funds to purchase bank wealth management products, securities firm wealth management products, trust wealth management products, and public or private funds issued by other financial institutions [2] - The maximum balance for this investment is set at 500 million yuan [2] - The decision has been approved by the company's fifth board of directors during its seventeenth meeting and does not require shareholder approval [2]